Terms: = Kidney tumors AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
12 results:
1. Co-immunization with L-Myc enhances CD8
Chai D; Zhang Z; Jiang N; Ding J; Qiu D; Shi SY; Wang G; Fang L; Li H; Tian H; Yang J; Zhang Q; Zheng J
Cancer Sci; 2021 Sep; 112(9):3469-3483. PubMed ID: 34157192
[TBL] [Abstract] [Full Text] [Related]
2. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract] [Full Text] [Related]
3. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis.
Duh MS; Dial E; Choueiri TK; Fournier AA; Antras L; Rodermund D; Neary MP; Oh WK
Curr Med Res Opin; 2009 Aug; 25(8):2081-90. PubMed ID: 19586325
[TBL] [Abstract] [Full Text] [Related]
4. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
[TBL] [Abstract] [Full Text] [Related]
5. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2.
Walsh AM; Bailly GG; Bell DG; Norman RW; Gupta R; Zayed E; Nassar BA
Can J Urol; 2003 Oct; 10(5):2000-6. PubMed ID: 14633328
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer.
Primdahl H; von der Maase H; Sørensen FB; Wolf H; Ørntoft TF
J Cancer Res Clin Oncol; 2002 Jun; 128(6):295-301. PubMed ID: 12073046
[TBL] [Abstract] [Full Text] [Related]
7. L-MYC allelotype in renal cell carcinoma.
Presti JC; Hinckley J; Reuter VE
Cancer Genet Cytogenet; 1996 May; 88(1):66-8. PubMed ID: 8630982
[TBL] [Abstract] [Full Text] [Related]
8. Variable expression of the interleukin-2 receptor alpha chain and MYC genes in lymphocytes from renal cell carcinoma patients treated with interleukin-2.
Hayat K; Finnegan M; Lee KA; Rees RC; Hancock BW; Goyns MH
Cancer Lett; 1992 Aug; 65(2):173-8. PubMed ID: 1511423
[TBL] [Abstract] [Full Text] [Related]
9. Association between restriction fragment length polymorphism of the L-myc gene and lung metastasis in human breast cancer.
Champeme MH; Bieche I; Latil A; Hacene K; Lidereau R
Int J Cancer; 1992 Jan; 50(1):6-9. PubMed ID: 1345822
[TBL] [Abstract] [Full Text] [Related]
10. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in genitourinary cancers.
Kakehi Y; Taki Y; Yoshida O
Urol Int; 1991; 47 Suppl 1():86-9. PubMed ID: 1683040
[TBL] [Abstract] [Full Text] [Related]
11. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.
Kakehi Y; Yoshida O
Int J Cancer; 1989 Mar; 43(3):391-4. PubMed ID: 2564378
[TBL] [Abstract] [Full Text] [Related]
12. Myc family of cellular oncogenes.
DePinho R; Mitsock L; Hatton K; Ferrier P; Zimmerman K; Legouy E; Tesfaye A; Collum R; Yancopoulos G; Nisen P
J Cell Biochem; 1987 Apr; 33(4):257-66. PubMed ID: 3034933
[TBL] [Abstract] [Full Text] [Related]
